Including Integrated Psychological Treatment as Part of Standard Medical Therapy for Patients With Schizophrenia
Centre de Recherche Fernand-Seguin of Hôpital Louis-H. Lafontaine, Montréal, Canada. Journal of Nervous & Mental Disease
(Impact Factor: 1.69).
08/2006; 194(7):463-70. DOI: 10.1097/01.nmd.0000225120.92431.29
To assess the clinical outcomes associated with the inclusion of Integrated Psychological Treatment (IPT) standard medical therapy in nine regular clinical settings, nine clinical teams integrated the complete IPT program (six hierarchically arranged subprograms) with their respective standard medical therapies for outpatients with schizophrenia. A total of 90 patients, young adults to long-term mentally ill patients, participated in the program. Patients were evaluated using standardized instruments at four time points: (1) prior to including the IPT program, (2) after the first three IPT subprograms, (3) at the end of IPT, and (4) 3 to 4 months post-IPT. The IPT program was associated with positive results. Patients improved in terms of overall symptoms, subjective experiences, cognitive and social functioning, and quality of life. IPT is one of the most up-to-date programs to address the rehabilitation needs of persons suffering from schizophrenia. Our experience in nine clinical settings suggests that IPT can successfully be included as part of standard medical therapy in the rehabilitation of patients with schizophrenia.
Available from: Helen-Maria Vasiliadis
[Show abstract] [Hide abstract]
ABSTRACT: Mental health policies, advocating outpatient as well as community mental health care for the severely mentally ill, are aiming towards health system cost containment and patient quality of life. Programs with cognitive behavioral therapy, such as the Integrated Psychological Therapy (IPT), added to standard medical therapy for patients with schizophrenia have been associated with improved outcomes. A Quebec version of the IPT program was integrated in outpatient clinics and improvements were observed in overall symptoms, subjective experiences, cognitive and social functioning, and quality of life. In light of these results we deemed it relevant to describe the health system cost and patient resource use associated with the program. The costs related to IPT have not been previously reported and this study will elucidate on effective health services and budget allocation needed to include IPT.
To describe health care resource use and related costs associated with participating in an IPT program included as standard medical therapy in nine clinical settings.
A cohort of patients with schizophrenia participating in the IPT program were followed up to one year preceding the start of the program and concurrently until the end to compare the resource use and costs incurred by patients with schizophrenia during their participation. A health and social service system and patient perspective was adopted, and the medical and non-medical costs associated with the IPT program were measured. Valuation (2001 CDN dollars) was based on information provided by provincial billing systems. Statistical differences were assessed using the Wilcoxon signed-rank test.
The IPT program induced a one time fixed cost (2347 dollars) for the training of mental health professionals and costs related to patient participation (1350 dollars). Our results show that there was an average decrease in health care system resource use per patient during the IPT program (26,133 dollars) as opposed to the preceding year (26,750 dollars). There was a significant decrease in the number of visits and in physician fees paid out to psychiatrists, the number of hospitalizations and related costs, and visits to the emergency department per patient during the IPT program as compared to the preceding year. No significant difference was observed in patient related costs which averaged 7295 dollars and 7537 dollars, before and during the IPT program, respectively.
Although the IPT program induces a one time fixed cost for training, the integration of IPT, as part of an individualized standard medical therapy, is associated with a change from inpatient towards outpatient resource use with no significant increase in health system related costs.
Given clinical and quality of life improvements, the findings suggest that offering IPT to more patients with severe mental illness may prove more cost beneficial by decreasing the health system related costs per user in the long term.
Additional research is needed to examine in parallel the long-term clinical and cost impact of the IPT program in different clinical settings (young adults to long term mentally ill). This will elucidate to which patient population IPT is most cost-effective.
The Journal of Mental Health Policy and Economics 01/2007; 9(4):201-7. · 0.97 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Schizophrenia severely impairs social insertion of patients. The therapeutic approach is now believed to be bio-psycho-social. Antipsychotic medication is necessary but not sufficient and needs to be completed by a rehabilitation program. The efficacy of the Integrated Psychological Treatment (IPT) program has been demonstrated in independent studies in Europe and North America. It is characterized by a combination of cognitive remediation and psychosocial approach. Authors present a study comparing the IPT program for stabilized patients treated in a day care center with standard treatment in the same type of setting. They use a variety of instruments for clinical, cognitive and functional evaluations.
Annales Médico-psychologiques revue psychiatrique 04/2007; 165(3):195-199. DOI:10.1016/j.amp.2007.01.007 · 0.22 Impact Factor
Available from: Gary Bruno Schmid
[Show abstract] [Hide abstract]
ABSTRACT: Since 1995 we have developed a depth-psychological, experience- and expression-oriented approach to group therapy for psychotic patients--"Phantasy Therapy"--complementary to the main-stream emphasis upon behavioural, learn- and goal-oriented methods.
A group psychotherapy for acute and remitting patients suffering from psychosis or schizophrenia is statistically evaluated under treatment-as-usual in a public psychiatric clinic.
Phantasy Therapy is compared to an alternative treatment (art therapy = AT) and a placebo group (PG; weekly ward gatherings) via cognitive testing before and after each session.
(1) Improvement of cognitive deficits over the first 4 sessions: session 1 (effect size d = 0 between all 3 groups) versus session 4 (d = 0.2 and 0.4 of Phantasy Therapy over AT and PG, respectively). Averaged over the first 4 sessions, the cognitive test showed tendential improvements for Phantasy Therapy and AT compared to PG. (2) Self-rating (sum of 4 item scores) averaged over the first 4 sessions showed a small effect. Patients judged themselves more improved after Phantasy Therapy compared to AT (d = 0.2) or PG (d = 0.3); tendential d (0.1) of AT over PG. (3) Psychosocial communication skills considerably improved during Phantasy Therapy, slightly worsened during AT, and remained relatively unchanged during PG. The effect sizes of Phantasy Therapy for values averaged over the first 4 sessions was 0.6 compared to AT and 0.4 compared to PG.
Phantasy Therapy is better than PG and at least as good as AT. These results should be hardened by further studies.
Forschende Komplementärmedizin / Research in Complementary Medicine 09/2007; 14(4):216-23. DOI:10.1159/0000106074
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.